Skip to content

Clinical trials

Completed Phase 2 Hodgkin Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hodgkin Disease Phase: Phase 2 Status: Completed Clear all

261 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200011
200111
20028
200310
200414
200518
200611
200712
200814
200911
201018
201115
201213
20139
20145
201514
20166
20179
20185
20192
20202
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed261

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center25
Memorial Sloan Kettering Cancer Center14
National Cancer Institute (NCI)13
M.D. Anderson Cancer Center9
Stanford University7
University of Cologne7
Alliance for Clinical Trials in Oncology6
Case Comprehensive Cancer Center6
Massachusetts General Hospital6
Barbara Ann Karmanos Cancer Institute5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hodgkin Disease261
Lymphoma, Non-Hodgkin138
Lymphoma119
Leukemia, Lymphocytic, Chronic, B-Cell108
Precursor Cell Lymphoblastic Leukemia-Lymphoma100
Multiple Myeloma90
Leukemia, Myeloid, Acute84
Lymphoma, Follicular84
Lymphoma, Mantle-Cell81
Lymphoma, Large B-Cell, Diffuse79

Trials

Showing 1 to 25 of 261. Each trial links to its page on Pharma Observatory.

161 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.